Revenue | ₹39.95Cr |
Net Profits | ₹20.36Cr |
Net Profit Margins | 50.96% |
Shukra Pharmaceuticals Ltd’s revenue jumped 244.69% since last year same period to ₹39.95Cr in the Q3 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 426.35% jump in its revenue since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit jumped 544.3% since last year same period to ₹20.36Cr in the Q3 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 755.46% jump in its net profits since last 3-months.
Shukra Pharmaceuticals Ltd’s net profit margin jumped 86.92% since last year same period to 50.96% in the Q3 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 62.53% jumped in its net profit margins since last 3-months.
The revenue for Shukra Pharmaceuticals Ltd in the Q3 results 2025 was ₹39.95Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q3 results 2025 was ₹20.36Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q3 results 2025 was 50.96%.
The revenue for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was ₹11.59Cr.
The net profit for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was ₹3.16Cr.
The net profit margin for Shukra Pharmaceuticals Ltd in the Q3 results 2024 was 27.26%.